載入...
Efficacy and economics of targeted panel versus whole exome sequencing in 878 patients with suspected primary immunodeficiency
BACKGROUND: NGS has become a first-line tool for diagnosis of PID. However, patient access remains limited due to restricted insurance coverage and a lack of guidelines addressing use of targeted panels vs WES. OBJECTIVES: To compare targeted next generation sequencing (NGS) with whole exome sequenc...
Na minha lista:
| 發表在: | J Allergy Clin Immunol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7870529/ https://ncbi.nlm.nih.gov/pubmed/32888943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.08.022 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|